Clinical Trial Update: Multi-CAR-T Cells Targeting B Cell Lymphomas [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update on multi-CAR-T cells targeting B cell lymphomas; status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoma

Snippet

Sponsor: Shenzhen Geno-Immune Medical Institute | Conditions: B Cell Lymphoma (BCL) | Phase 1, Phase 2 | Status: UNKNOWN